Citaat | Rechtbank Den Haag 27 juli 2016

Onder 2.6. Rechtbank Den Haag 27 juli 2016

Een alinea uit Rechtbank Den Haag 27 juli 2016, ECLI:NL:RBDHA:2016:8596.

[0021] The medicaments of the present invention are administered subcutaneously. In particular, the medicaments are administered by subcutaneous injection, furthermore preferred that the medicament be present in a form which allows subcutaneous self-administration by the patient (self-application). Such a treatment of subcutaneous self-administration has for example proven successful in the administration of insulin by the diabetic himself and leads to a high degree of treatment acceptance on the part of the patient (patient compliance). In the case of the treatment of rheumatism, self-application also has the advantage that the weekly doctor's visit is no longer necessary.

Zelf controleren

Voor dit citaat hoeft niemand Bron op zijn woord te geloven. Het document dat rechtspraak.nl publiceerde, staat op https://bron.page/api/v1/blobs/8f842dbfd37efdf2d5055bb9e5cc85a38df4f8e931abef458724fcb63e78d19e. Wie het ophaalt en de SHA-256 ervan berekent, krijgt 8f842dbfd37efdf2d5055bb9e5cc85a38df4f8e931abef458724fcb63e78d19e, en de alinea staat in dat document op bytes 32685 tot 33380.